Your browser doesn't support javascript.
loading
Is 30-Day Mortality after Admission for Heart Failure an Appropriate Metric for Quality?
Faillace, Robert T; Yost, Gregory W; Chugh, Yashasvi; Adams, Jeffrey; Verma, Beni R; Said, Zaid; Sayed, Ibrahim Ismail; Honushefsky, Ashley; Doddamani, Sanjay; Berger, Peter B.
Afiliação
  • Faillace RT; Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY. Electronic address: Robert.Faillace@nychhc.org.
  • Yost GW; Conemaugh Memorial Medical Center, Johnstown, Pa.
  • Chugh Y; Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY.
  • Adams J; Geisinger Medical Center, Danville, Pa.
  • Verma BR; Cleveland Clinic, Ohio.
  • Said Z; University of Buffalo, NY.
  • Sayed II; Geisinger Medical Center, Danville, Pa.
  • Honushefsky A; Geisinger Medical Center, Danville, Pa.
  • Doddamani S; Geisinger Medical Center, Danville, Pa.
  • Berger PB; Carmel, NY.
Am J Med ; 131(2): 201.e9-201.e15, 2018 02.
Article em En | MEDLINE | ID: mdl-28941750
ABSTRACT

BACKGROUND:

The Centers for Medicare and Medicaid Services (CMS) model for publicly reporting national 30-day-risk-adjusted mortality rates for patients admitted with heart failure fails to include clinical variables known to impact total mortality or take into consideration the culture of end-of-life care. We sought to determine if those variables were related to the 30-day mortality of heart failure patients at Geisinger Medical Center.

METHODS:

Electronic records were searched for patients with a diagnosis of heart failure who died from any cause during hospitalization or within 30 days of admission.

RESULTS:

There were 646 heart-failure-related admissions among 530 patients (1.2 admissions/patient). Sixty-seven of the 530 (13%) patients died 35 (52%) died during their hospitalization and 32 (48%) died after discharge but within 30 days of admission; of these, 27 (40%) had been transferred in for higher-acuity care. Fifty-one (76%) died from heart failure, and 16 (24%) from other causes. Fifty-five (82%) patients were classified as American Heart Association Stage D, 58 (87%) as New York Heart Association Class IV, and 30 (45%) had right-ventricular systolic dysfunction. None of the 32 patients who died after discharge met recommendations for beta-blockers. Criteria for prescribing angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and mineralocorticoid receptor blockers were not met by 33 of the 34 patients (97%) with heart failure with reduced ejection fraction not on one of those drugs. Fifty-seven patients (85%) had a do-not-resuscitate (DNR) status.

CONCLUSION:

A majority of heart failure-related mortality was among patients who opted for a DNR status with end-stage heart failure, limiting the appropriateness of administering evidence-based therapies. No care gaps were identified that contributed to mortality at our institution. The CMS 30-day model fails to take important variables into consideration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade da Assistência à Saúde / Mortalidade Hospitalar / Insuficiência Cardíaca Tipo de estudo: Guideline / Prognostic_studies Aspecto: Ethics Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Med Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade da Assistência à Saúde / Mortalidade Hospitalar / Insuficiência Cardíaca Tipo de estudo: Guideline / Prognostic_studies Aspecto: Ethics Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Med Ano de publicação: 2018 Tipo de documento: Article